日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Magnetic Resonance Imaging-Directed Stereotactic Body Radiation Therapy Microboost in Concert With Pelvic Nodal Irradiation for Prostate Cancer in the Higher-Risk Spectrum: Toxicity

磁共振成像引导立体定向放射治疗微剂量增强联合盆腔淋巴结照射治疗高危前列腺癌:毒性

Musthafa, Mina; Wells, Markus; Kearney, Timothy; Vizcaino, Brianna; Santos, Vianca F; Sanchez, Astrid; Mendez, Christopher; Katz, Aaron; Kowalcyzk, Keith; Hankins, Ryan; Gupta, Mohit; Lepor, Herbert; Haas, Jonathan A; Lischalk, Jonathan W

IgG4-Related Disease Presenting With Diffuse Coronary Atherosclerosis Characterized by Marked Lipid-Rich Necrotic Core Burden

IgG4相关疾病表现为弥漫性冠状动脉粥样硬化,其特征是富含脂质的坏死核心负荷显著

Elisarraras, Francisco X; Pelberg, Robert A; Roberts, Jacob S; Shah, Jay A; Xia, Jeffrey; Sayed, Sammy; Lepor, Norman E; Aldana-Bitar, Jairo; Karlsberg, Ronald P; Cho, Geoffrey

Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers: Results From the OCEAN(a)-DOSE Trial

Olpasiran、氧化磷脂和系统性炎症生物标志物:OCEAN(a)-DOSE试验的结果

Rosenson, Robert S; López, J Antonio G; Gaudet, Daniel; Baum, Seth J; Stout, Elmer; Lepor, Norman E; Park, Jeong-Gun; Murphy, Sabina A; Knusel, Beat; Wang, Jingying; Wilmanski, Tomaz; Wang, Huei; Wu, You; Kassahun, Helina; Sabatine, Marc S; O'Donoghue, Michelle L

MRI performance to identify clinically significant prostate cancer following focal cryo-ablation

磁共振成像在局部冷冻消融术后识别具有临床意义的前列腺癌方面的性能

Lepor, Herbert; Parry, Samuel; Tafa, Majlinda; Rapoport, Eli; Wysock, James S

High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation

采用立体定向放射治疗增强治疗盆腔淋巴结照射后的高危前列腺癌

Lischalk, Jonathan W; Akerman, Meredith; Repka, Michael C; Sanchez, Astrid; Mendez, Christopher; Santos, Vianca F; Carpenter, Todd; Wise, David; Corcoran, Anthony; Lepor, Herbert; Katz, Aaron; Haas, Jonathan A

High-volume prostate biopsy core involvement is not associated with an increased risk of cancer recurrence following 5-fraction stereotactic body radiation therapy monotherapy

高容量前列腺活检穿刺活检组织受累与5次立体定向放射治疗单药治疗后癌症复发风险增加无关。

Lischalk, Jonathan W; Sanchez, Astrid; Santos, Vianca F; Mendez, Christopher; Akerman, Meredith; Carpenter, Todd; Tam, Moses; Byun, David; Wise, David R; Mahadevan, Anand; Evans, Andrew; Huang, William; Katz, Aaron; Lepor, Herbert; Haas, Jonathan A

Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum

低密度脂蛋白胆固醇管理策略的演变:针对不同风险阶段预防动脉粥样硬化性心血管疾病的个性化方法

Wilkinson, Michael J; Lepor, Norman E; Michos, Erin D

Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa

阿贝拉西单抗(MAA868)是一种新型的因子XI和因子XIa双重抑制剂,其药代动力学和药效学研究

Yi, B Alexander; Freedholm, Debra; Widener, Nancy; Wang, Xiaohui; Simard, Emilie; Cullen, Constance; Al-Saady, Naab M; Lepor, Norman E; Coulter, Sara; Lovern, Mark; Bloomfield, Dan

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases

DCRM多专科实践指南:糖尿病、心肾和代谢疾病的管理

Handelsman, Yehuda; Anderson, John E; Bakris, George L; Ballantyne, Christie M; Beckman, Joshua A; Bhatt, Deepak L; Bloomgarden, Zachary T; Bozkurt, Biykem; Budoff, Matthew J; Butler, Javed; Dagogo-Jack, Samuel; de Boer, Ian H; DeFronzo, Ralph A; Eckel, Robert H; Einhorn, Daniel; Fonseca, Vivian A; Green, Jennifer B; Grunberger, George; Guerin, Chris; Inzucchi, Silvio E; Jellinger, Paul S; Kosiborod, Mikhail N; Kushner, Pamela; Lepor, Norman; Mende, Christian W; Michos, Erin D; Plutzky, Jorge; Taub, Pam R; Umpierrez, Guillermo E; Vaduganathan, Muthiah; Weir, Matthew R

Axumin ((18)F-Fluciclovine) PET imaging in men exhibiting no clinically significant cancer on initial negative biopsy of PI-RADS 4 and 5 regions of interest

在初始活检结果为阴性的PI-RADS 4和5感兴趣区域内,未发现临床意义显著癌症的男性患者接受Axumin((18)F-氟西克洛文)PET显像

Becher, Ezequiel; Karls, Shawn; Tong, Angela; Wysock, James S; Taneja, Samir S; Huang, William C; Lepor, Herbert